Contact
Please use this form to send email to PR contact of this press release:
A1C Drink Inc. Announces Start of Clinical Trials in Early 2025, Targeting a Breakthrough in Diabetes Management
TO:
Russ McCullough
A1C Drink, Inc.
+1 913.386.7811